House Democrats sent letters to the potential buyers of the genetic testing company, asking how they plan to protect customer ...

Regeneron Pharmaceuticals said on Monday it will buy genomics firm 23andMe Holding for $256 million through a bankruptcy ...

The future of the genetic data owned by 23andMe is uncertain as the company undergoes a court-supervised sale.

An independent privacy official will oversee 23andMe’s proposed sale after Illinois and 26 other states raised concerns about ...

Lawmakers raised questions and concerns about the sale of genetic-testing company 23andMe during a hearing on Tuesday.

Twenty-seven states and the District of Columbia have filed a lawsuit in bankruptcy court seeking to block the sale of ...

The genetic-testing company, which collected DNA data from users, is for sale in bankruptcy court. Now, 27 states and the ...

WilmerHale said it’s representing the law professor tapped to make privacy-related recommendations about the sale of ...

( NewsNation) — The interim CEO of 23andMe will face questions from lawmakers Wednesday about the DNA company’s data privacy amid a multistate lawsuit about its customers’ genetic data. The Senate ...

Regneron stock crashed today following disappointing COPD trials data. Here's what makes REGN shares worth buying on the ...

Lawmakers want to know what will be done to make sure consumer genetic testing company 23andMe’s data will stay out of the ...

People did not submit their personal data to 23andMe thinking their genetic blueprint would later be sold off to the highest ...